Stock Quotes in this Article: ARWR, BCRX, EDAP, OMTH, NSPR

MADISON, Wis. (Stockpickr) -- At Stockpickr, we track daily portfolios of stocks that are the biggest percentage gainers and the biggest percentage losers.

Stocks that are making large moves like these are favorites among short-term traders because they can jump into these names and try to capture some of that massive volatility. Stocks that are making big-percentage moves either up or down are usually in play because their sector is becoming attractive or they have a major fundamental catalyst such as a recent earnings release. Sometimes stocks making big moves have been hit with an analyst upgrade or an analyst downgrade.

>>5 Stocks Poised for Breakouts

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits. If you time your trade correctly, combining technical indicators with fundamental trends, discipline and sound money management, you will be well on your way to investment success.

With that in mind, let's take a closer look at a several stocks under $10 that are making large moves to the upside today.

>>5 Rocket Stocks to Buy for May

BioCryst Pharmaceuticals

BioCryst Pharmaceuticals (BCRX) is a biotechnology company that designs, optimizes and develops novel drugs that block key enzymes involved in cancer, viral infections and autoimmune diseases. This stock is trading up 2% to $2.01 in recent trading.

Today’s Range: $1.92-$2.09

52-Week Range: $1.08-$4.95

Volume: 3.73 million

Three-Month Average Volume: 1.21 million

>>3 Health Care Stocks Rising on Big Volume

From a technical perspective, BCRX is uptrending modestly here right above some near-term support at $1.80 with heavy upside volume. This move is quickly pushing shares of BCRX within range of triggering a major breakout trade. That trade will hit if BCRX manages to take out some near-term overhead resistance levels at $2.09 to $2.21 with high volume.

Traders should now look for long-biased trades in BCRX as long as it’s trending above today’s low of $1.92 and then once it sustains a move or close above those breakout levels with volume that hits near or above 1.21 million shares. If that breakout triggers soon, then BCRX will set up to re-test or possibly take out its next major overhead resistance levels at its 200-day of $2.57 or at $2.88. Any high-volume move above $2.88 could then send BCRX towards $3 to $3.25.

Edap TMS SA

Edap TMS SA (EDAP) develops, produces and markets minimally invasive medical devices, mainly for urological diseases. This stock is trading up 6% to $3.84 in recent trading.

Today’s Range: $3.56-$3.92

52-Week Range: $1.43-$4.94

Volume: 150,000

Three-Month Average Volume: 313,224

>>5 Hated Earnings Stocks That Deserve Your Love

From a technical perspective, EDAP is ripping higher here right above some near-term support at $3.45 with lighter-than-average volume. This stock has been consolidating for the last month, after shares fell from $4.94 to $3.25. Shares of EDAP are now quickly moving within range of triggering a near-term breakout trade. That trade will hit if EDAP manages to take out its 50-day at $3.92 and then once it clears more resistance at $4.05 with high volume.

Traders should now look for long-biased trades in EDAP as long as it’s trending above $3.45 and then once it sustains a move or close above those breakout levels with volume that hits near or above 313,224 shares. If that breakout triggers soon, then EDAP will set up to re-test or possibly take out its next major overhead resistance levels at $4.25 to $4.50. Any high-volume move above $4.50 will then put $4.75 to $4.94 into range for shares of EDAP.

Arrowhead Research

Arrowhead Research (ARWR) is a development stage nanotechnology holding company that forms, acquires, and operates subsidiaries commercializing innovative nanotechnologies. This is trading up 12.2% to $2.04 in recent trading.

Today’s Range: $1.80-$2.08

52-Week Range: $1.65-$5.79

Volume: 141,000

Three-Month Average Volume: 121,952

Shares of ARWR are soaring higher after the company announced the pricing of a private offering with gross proceeds expected to be $36 million. The offering was priced at $1.83 per share.

From a technical perspective, ARWR is soaring here back above some near-term overhead resistance at $1.95 and back above its 50-day moving average at $2.07 with above-average volume. At last check, ARWR has hit an intraday high of $2.09 and volume is just starting to surpass its three-month average action of 121,952 shares.

Traders should now look for long-biased trades in ARWR as long as it’s trending above $1.95 and then once it sustains a move or close above its 50-day at $2.07 with volume that hits near or above 121,952 shares. If that breakout hits soon, then ARWR will set up to re-test or possibly take out its next major overhead resistance levels at $2.25 to its 200-day at $2.41. Any high-volume move above $2.41 will then put $2.55 to $2.70 into range for shares of ARWR.

Omthera Pharmaceuticals

Omthera Pharmaceuticals (OMTH) is focused on the development and commercialization of new therapies for abnormalities in blood lipids, referred to as dyslipidemia, and the treatment of cardiovascular disease. This stock is trading up 4.4% to $7.55 in recent trading.

Today’s Range: $7.40-$7.70

52-Week Range: $5.69-$7.80

Volume: 76,000

Three-Month Average Volume: 325,762

From a technical perspective, OMTH is spiking sharply higher here with lighter-than-average volume. This move is quickly pushing shares of OMTH within range of triggering a major breakout trade. That trade will hit if OMTH manages to take out its all-time high at $7.80 with high volume.

Traders should now look for long-biased trades in OMTH as long as it’s trending above $7.20 and then once it sustains a move or close above $7.70 to $7.80 with volume that hits near or above 325,762 shares. If that breakout triggers soon, then OMTH will set up to enter new all-time-high territory, which is bullish technical price action. Some possible upside targets off that breakout are $8.50 to $9 in the near-term.

InspiredMD

InspiredMD (NSPR) is a medical device company focusing on the development and commercialization of its proprietary stent platform technology, MGuard. This stock is trading up 2.3% to $2.59 in recent trading.

Today’s Range: $2.44-$2.65

52-Week Range: $1.88-$10.16

Volume: 313,000

Three-Month Average Volume: 99,632

From a technical perspective, NSPR is trending higher here right off its 50-day moving average at $2.42 with heavy upside volume. This stock has been getting heavy upside volume flows for the last few weeks, which is bullish technical action. Shares of NSPR are now quickly moving within range of triggering a major breakout trade. That trade will hit if NSPR manages to take out some near-term overhead resistance levels at $2.85 to $3 with high volume.

Traders should now look for long-biased trades in NSPR as long as it’s trending above its 50-day at $2.42 and then once it sustains a move or close above those breakout levels with volume that hits near or above 99,632 shares. If that breakout triggers soon, then NSPR will set up re-test or possibly take out its next major overhead resistance levels at $3.55 to $4.25. This stock could even tag its 200-day at $4.80 if it breaks out soon and catches some momentum buying.

To see more stocks that are making notable moves higher today, check out the Stocks Under $10 Moving Higher portfolio on Stockpickr.

-- Written by Roberto Pedone in Madison, Wis.

RELATED LINKS:

>>5 REITs You Should Buy in May
>>4 Stocks Looking to Break Out

>>Stocks Are Doomed. Buy More Stocks.

Follow Stockpickr on Twitter and become a fan on Facebook.

At the time of publication, author had no positions in stocks mentioned.

Roberto Pedone, based out of Madison, Wis., is an independent trader who focuses on technical analysis for small- and large-cap stocks, options, futures, commodities and currencies. Roberto studied international business at the Milwaukee School of Engineering, and he spent a year overseas studying business in Lubeck, Germany. His work has appeared on financial outlets including CNBC.com and Forbes.com. You can follow Pedone on Twitter at www.twitter.com/zerosum24 or @zerosum24.